Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAberd Asia Inc Regulatory News (AAIF)

Share Price Information for Aberd Asia Inc (AAIF)

Share Price is delayed by 15 minutes
Get Live Data
337.00    -6.00 (-1.75%)
Bid:
336.00
Ask:
339.00
Spread: 3.00 (0.893%)
Market Cap: £480.28m
AAIF Live PriceLast checked at - London Stock Exchange

Intraday Aberd Asia Inc Share Chart

Third Interim Dividend

15 Oct 2025 10:57

RNS Number : 5035D
Aberdeen Asian Income Fund Limited
15 October 2025
 

Aberdeen Asian Income Fund Limited (the "Company")

Legal Entity Identifier (LEI): 549300U76MLZF5F8MN87

 

15 October 2025

 

Declaration of Third Interim Dividend

 

 

Highlights

 

· Annualised dividend yield of 6.4%.

· Quarterly interim dividend of 4.29p per share.

· Third dividend payment announced by the Company since the introduction of the enhanced dividend policy.

 

The Board is pleased to declare a third quarterly interim dividend of 4.29p per share for the year ended 31 December 2025. This is the third dividend payment announced by the Company since the introduction of the enhanced dividend policy earlier this year, to broaden the appeal of the Company's shares to a wider range of investors and to reflect the sustained investor appetite for yield in the current interest rate environment. Taking into account the first and second interim dividends already paid, this equates to an annualised dividend yield of 6.4%.

 

The third interim dividend will be paid on 21 November 2025 to shareholders on the register at the close of business on 24 October 2025. The ex-dividend date is 23 October 2025. The Company offers the option for shareholders to invest their dividend in a Dividend Reinvestment Plan ("DRIP"), which is managed by the Company's Registrar, Computershare Investor Services PLC. The deadline for elections under the DRIP is 31 October 2025.

 

Note:

The Company's dividend policy, as announced on 16 January 2025, is to set the dividend at 1.5625% per quarter of the Company's net asset value ("NAV"), equating to approximately 6.25% of NAV per annum. The dividend is calculated using the Company's NAV on the last business day of the preceding financial quarter (i.e. the end of March, June, September and December). The third quarterly interim dividend of 4.29p per share is based on 1.5625% of the Company's NAV of 274.52p per share as at 30 September 2025.The dividend yield of 6.4% is based on a share price of 251p on 30 September 2025.

 

 

For further information, please contact:

 

Aberdeen (Investment Manager):

Ben Heatley, Head of Closed End Fund Sales

Ben.Heatley@aberdeenplc.com

 

Maria Allen, Client Director, Closed End Funds

Maria.Allen@aberdeenplc.com

 

Peel Hunt LLP (Corporate Broker):

Luke Simpson, Huw Jeremy (Investment Banking)

Alex Howe, Richard Harris (Sales)

020 7418 8900

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVMABLTMTABMAA
Date   Source Headline
13th Apr 20269:04 amRNSPortfolio disclosure
10th Apr 202611:59 amRNSNet Asset Value(s)
9th Apr 202611:23 amRNSNet Asset Value(s)
8th Apr 20262:00 pmRNSMonth End Net Asset Value(s)
8th Apr 202611:45 amRNSNet Asset Value(s)
7th Apr 20264:20 pmRNSDoc re. Annual Report
7th Apr 20261:14 pmRNSGearing Disclosure
7th Apr 202612:19 pmRNSNet Asset Value(s)
31st Mar 202611:58 amRNSNet Asset Value(s)
30th Mar 20263:13 pmRNSGearing disclosure
30th Mar 202612:16 pmRNSNet Asset Value(s)
27th Mar 202611:54 amRNSNet Asset Value(s)
27th Mar 20268:59 amRNS-RQuotedData's In The HotSeat Special
26th Mar 202611:51 amRNSNet Asset Value(s)
25th Mar 202611:42 amRNSNet Asset Value(s)
24th Mar 202611:18 amRNSNet Asset Value(s)
24th Mar 202610:42 amRNSGearing Disclosures
23rd Mar 202612:17 pmRNSNet Asset Value(s)
20th Mar 202611:50 amRNSNet Asset Value(s)
19th Mar 202611:58 amRNSNet Asset Value(s)
18th Mar 202612:22 pmRNSNet Asset Value(s)
18th Mar 20267:00 amRNSAnnual Financial Report
17th Mar 202610:40 amRNSNet Asset Value(s)
16th Mar 20262:10 pmRNSGearing disclosure
16th Mar 20262:10 pmRNSGearing disclosure
16th Mar 202612:18 pmRNSNet Asset Value(s)
13th Mar 202612:20 pmRNSNet Asset Value(s)
13th Mar 20268:45 amRNSPortfolio disclosure
13th Mar 20268:45 amRNSPortfolio disclosure
11th Mar 202611:59 amRNSNet Asset Value(s)
10th Mar 202611:34 amRNSNet Asset Value(s)
9th Mar 20261:08 pmRNSGearing Disclosures
9th Mar 20261:08 pmRNSGearing Disclosures
9th Mar 202611:46 amRNSNet Asset Value(s)
6th Mar 202612:24 pmRNSNet Asset Value(s)
5th Mar 20262:00 pmRNSMonth End Net Asset Value(s)
5th Mar 202611:50 amRNSNet Asset Value(s)
4th Mar 202611:10 amRNSNet Asset Value(s)
3rd Mar 202610:50 amRNSNet Asset Value(s)
2nd Mar 20262:55 pmRNSGearing disclosure
27th Feb 20262:39 pmRNSLoan Renewal
27th Feb 202612:26 pmRNSNet Asset Value(s)
26th Feb 202612:25 pmRNSNet Asset Value(s)
25th Feb 202612:08 pmRNSNet Asset Value(s)
24th Feb 202611:57 amRNSNet Asset Value(s)
23rd Feb 202612:38 pmRNSGearing disclosure
23rd Feb 202612:05 pmRNSNet Asset Value(s)
20th Feb 202611:18 amRNSNet Asset Value(s)
19th Feb 202612:22 pmRNSNet Asset Value(s)
18th Feb 202611:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.